A vaccine made by Wuhan Institute of Virology has been inoculated on 2000 people (unactivated
It is so in Phase II of clinical trials, it could be on market at the end of 2020.
This vaccine will be made with Beijing Institute of Biological Products participation.
Both are affiliated to state-owned Sinopharm group.
China is already preparing industry to produce that vaccine (Beijing Institute of Biological Products has capacity to produce around 120 millions of dose each year).
Read more here :
As a reminder, China already has five coronavirus vaccines in human trials